Review
Immunology
Xiaoqing Chen, Xue Liu, Yichao Jiang, Ningshao Xia, Chao Liu, Wenxin Luo
Summary: Chronic hepatitis B virus (HBV) infection is a major public health challenge, with over 250 million people worldwide infected. Priming of naive HBV-specific CD8 T cells is hindered, and this is closely related to abnormalities in the complex immune microenvironment. In this article, we summarize recent progress in understanding the abnormal priming of HBV-specific CD8 T cells and discuss corresponding immunotherapies to facilitate their functional recovery. We also highlight the importance of balancing viral clearance and pathological liver injury induced by CD8 T-cell activation during drug development.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Biology
Chansavath Phetsouphanh, Prabhjeet Phalora, Carl-Philipp Hackstein, John Thornhill, C. Mee Ling Munier, Jodi Meyerowitz, Lyle Murray, Cloete VanVuuren, Dominique Goedhals, Linnea Drexhage, Rebecca Moore, Quentin J. Sattentau, Jeffrey Yw Mak, David P. Fairlie, Sarah Fidler, Anthony D. Kelleher, John Frater, Paul Klenerman
Summary: Human MAIT cells play a crucial role in HIV-1 infection by inhibiting viral replication and protecting the host from infection. They are activated by IL-12 and IL-18, leading to the release of various cytokines upon activation.
Article
Immunology
Wenxing Su, Ji Zhang, Shun Yang, Minhui Tang, Yu Shen, Cuiping Liu, Jiang Ji, Marcus Maurer, Qingqing Jiao
Summary: This study explored the expression of Gal-9 and TIM-3 in AD patients and found that both Gal-9 and TIM-3 levels were higher in AD patients than in healthy controls. These levels were associated with disease activity, IgE levels, and circulating eosinophils and/or B cells. Furthermore, Gal-9 was found to inhibit T cell proliferation and induce apoptosis in AD patients.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Huifang Xiong, Guohui Xue, Yuting Zhang, Shuang Wu, Qiaoyun Zhao, Rulin Zhao, Nanjin Zhou, Yong Xie
Summary: The study aimed to investigate the effects of Gal-9 on experimental colitis. The results showed that exogenous Gal-9 increased Tim-3 expression, inhibited the TLR4/NF-kappa B pathway, and alleviated TNBS-induced colitis in mice. However, it had no reducing effect on DSS-induced colitis.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2023)
Article
Dermatology
Raquel Castillo-Gonzalez, Danay Cibrian, Nieves Fernandez-Gallego, Marta Ramirez-Huesca, Maria Laura Saiz, Maria N. Navarro, Manuel Fresno, Hortensia de la Fuente, Francisco Sanchez-Madrid
Summary: Allergic contact dermatitis is a common T-cell-mediated inflammatory skin disease characterized by red, itchy, swollen, and cracked skin. The absence of endogenous Gal-1 in CD8+ T cells plays a protective role in controlling the development of allergic contact dermatitis, as Gal-1-deficient mice display more sustained and severe skin inflammation after treatment.
JOURNAL OF INVESTIGATIVE DERMATOLOGY
(2021)
Article
Oncology
Katsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, Koji Tsuta, Mitsugu Sekimoto, Tomoharu Sugie
Summary: TIM-3 expression is associated with poorer prognosis in TNBC, possibly as a result of suppression of anticancer immunosurveillance. Galectin-9 and TIM-3 double-positivity is significantly associated with a more favourable prognosis compared with galectin-9 and/or TIM-3 negativity.
Article
Multidisciplinary Sciences
Alejandro J. Cagnoni, Maria Laura Giribaldi, Ada G. Blidner, Anabela M. Cutine, Sabrina G. Gatto, Rosa M. Morales, Mariana Salatino, Martin C. Abba, Diego O. Croci, Karina V. Marino, Gabriel A. Rabinovich
Summary: Colorectal cancer is a common malignancy with limited response to immunotherapy, prompting the need for new biomarkers and therapeutic targets. Gal-1, as an endogenous glycan-binding protein, has been found to influence the activity of CD8(+) regulatory T cells in CRC, suggesting a potential immunotherapeutic approach for this disease.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Article
Cell Biology
Jennifer L. Hope, Dennis C. Otero, Eun-Ah Bae, Christopher J. Stairiker, Ashley B. Palete, Hannah A. Faso, Michelle Lin, Monique L. Henriquez, Sreeja Roy, Hyungseok Seo, Xue Lei, Eric S. Wang, Savio Chow, Roberto Tinoco, Gregory A. Daniels, Kevin Yip, Alexandre Rosa Campos, Jun Yin, Peter D. Adams, Anjana Rao, Linda M. Bradley
Summary: PSGL-1 is a T cell-intrinsic checkpoint regulator that acts upstream of PD-1 and requires co-ligation with the TCR to attenuate T cell activation and drive terminal T cell exhaustion. PSGL-1 directly restrains TCR signaling via Zap70 and maintains expression of the Zap70 inhibitor Sts-1. Deficiency of PSGL-1 empowers CD8+ T cells to respond to low-affinity TCR ligands and inhibit the growth of PD-1-blockade-resistant melanoma.
Article
Cell Biology
Yujiao Wu, Qianying Yu, Meng Zhang, Yao Zhou, Xiao Su, Min Wu, Jiajia Lv, Zhenwei Xia
Summary: HO-1 modulates asthmatic airway inflammation by releasing DCEVs from dendritic cells, which facilitates regulatory T cell differentiation, reduces inflammatory cell infiltration and mucus secretion.
JOURNAL OF LEUKOCYTE BIOLOGY
(2022)
Article
Gastroenterology & Hepatology
Janine Kemming, Swantje Gundlach, Marcus Panning, Daniela Huzly, Jiabin Huang, Marc Luetgehetmann, Sven Pischke, Julian Schulze Zur Wiesch, Florian Emmerich, Sian Llewellyn-Lacey, David A. Price, Yakup Tanriver, Klaus Warnatz, Tobias Boettler, Robert Thimme, Maike Hofmann, Nicole Fischer, Christoph Neumann-Haefelin
Summary: Chronic HEV infection is associated with exhaustion of HEV-specific CD8+ T cells, indicating that T-cell failure is driven by persistent antigen recognition in severely immunosuppressed hosts. Functional reinvigoration of virus-specific T cells is at least partially possible when the antigen is cleared. Viral escape in a minority of patients also contributes to the failure of HEV-specific CD8+ T cells.
JOURNAL OF HEPATOLOGY
(2022)
Article
Immunology
Zhengping Wei, Pingfei Li, Ran He, Huicheng Liu, Na Liu, Yu Xia, Guoyu Bi, Qiuyang Du, Minghui Xia, Lei Pei, Jing Wang, Guihua Wang, Zhao-Hui Tang, Xiang Cheng, Huabin Li, Zhuoya Li, Lilin Ye, Arian Laurence, Youming Lu, Xiang-Ping Yang
Summary: The study demonstrates the essential roles of both the kinase activity and death domain of DAPK1 in maximal mTOR activation and CD8(+) T-cell function, shedding light on a novel mechanism where TCR-induced DAPK1 activation interacts with TSC2 to mediate mTORC1 activation. This mechanism is crucial for optimal CD8(+) T-cell function and antiviral responses in infections like LCMV.
CELLULAR & MOLECULAR IMMUNOLOGY
(2021)
Article
Immunology
Zhilin Peng, Yiwen Zhang, Xiancai Ma, Mo Zhou, Shiyu Wu, Zheng Song, Yaochang Yuan, Yingshi Chen, Yuzhuang Li, Guanwen Wang, Feng Huang, Yidan Qiao, Baijing Xia, Weiwei Liu, Jun Liu, Xu Zhang, Xin He, Ting Pan, Hanshi Xu, Hui Zhang
Summary: The study highlights the significant role of Brd4 in regulating glucose metabolism and maintaining receptor expression in CD8(+) T cells' homeostasis and immune response.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Biology
Oksana Tsyklauri, Tereza Chadimova, Veronika Niederlova, Jirina Kovarova, Juraj Michalik, Iva Malatova, Sarka Janusova, Olha Ivashchenko, Helene Rossez, Ales Drobek, Hana Vecerova, Virginie Galati, Marek Kovar, Ondrej Stepanek
Summary: In this study, it was identified that Tregs limit the availability of IL-2, thereby suppressing the formation of a previously uncharacterized subset of antigen-stimulated KILR CD8(+) effector T cells. These KILR CD8(+) T cells exhibit superior cell-killing abilities and can be induced by the administration of agonistic IL-2 immunocomplexes. This research has potential implications for immunotherapy targeting these cells in humans.
Review
Oncology
Yizi Cong, Jing Liu, Gang Chen, Guangdong Qiao
Summary: Cancer treatment using immune checkpoint receptor blockade has advanced, but resistance to current immune checkpoint inhibitors is a challenge. Tim-3 is a novel immune checkpoint molecule that could be a potential therapeutic target for breast cancer immunotherapy. Genetic polymorphisms in the Tim-3 gene may increase susceptibility to breast cancer, and Tim-3 expression correlates with treatment outcomes and prognosis in breast cancer patients.
FRONTIERS IN ONCOLOGY
(2021)
Article
Immunology
Siyu Liu, Chang Xu, Fan Yang, Lu Zong, Yizu Qin, Yufeng Gao, Qian Su, Tuantuan Li, Ye Li, Yuanhong Xu, Meijuan Zheng
Summary: The antiviral response of NK cells and CD8(+) T cells is weak in patients with CHB, and the overexpression of Gal-9 contributes to NK cell dysfunction and CD8(+) T cell exhaustion. Blocking Gal-9 or TIM-3 can restore the function of CD8(+) T cells.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Joseph S. Dolina, Sylvia Cechova, Christine K. Rudy, Sun-Sang J. Sung, William W. Tang, Joey Lee, Young S. Hahn, Thu H. Le
JOURNAL OF IMMUNOLOGY
(2017)
Article
Immunology
Matthew G. Lassen, John R. Lukens, Joseph S. Dolina, Michael G. Brown, Young S. Hahn
JOURNAL OF IMMUNOLOGY
(2010)
Article
Multidisciplinary Sciences
John R. Lukens, Joseph S. Dolina, Taeg S. Kim, Robert S. Tacke, Young S. Hahn
Article
Medicine, Research & Experimental
Joseph S. Dolina, Sun-Sang J. Sung, Tatiana I. Novobrantseva, Tuyen M. Nguyen, Young S. Hahn
MOLECULAR THERAPY-NUCLEIC ACIDS
(2013)
Article
Immunology
Ana L. Chiodetti, Maria F. Sanchez Vallecillo, Joseph S. Dolina, Maria I. Crespo, Constanza Marin, Stephen P. Schoenberger, Daniel A. Allemandi, Santiago D. Palma, Maria C. Pistoresi-Palencia, Gabriel Moron, Belkys A. Maletto
FRONTIERS IN IMMUNOLOGY
(2018)
Article
Cell Biology
Joseph S. Dolina, Joey Lee, Ryan Q. Griswold, Lara Labarta-Bajo, Sumetha Kannan, Jason A. Greenbaum, Nawal Bahia El Idrissi, Margot J. Pont, Michael Croft, Stephen P. Schoenberger
Review
Immunology
Joseph S. Dolina, Natalija Van Braeckel-Budimir, Graham D. Thomas, Shahram Salek-Ardakani
Summary: Recent research has revealed the heterogeneity within the exhausted CD8(+) T cell lineage, which consists of multiple interconnected subpopulations with distinct characteristics and locations. This understanding calls for a re-focusing of cancer immunotherapies on targeting the driver mechanisms underlying CD8(+) T(ex) development to stabilize functional subsets.
FRONTIERS IN IMMUNOLOGY
(2021)
Review
Oncology
Natalija Budimir, Graham D. Thomas, Joseph S. Dolina, Shahram Salek-Ardakani
Summary: Anti-PD-1/PD-L1 immune checkpoint blockade therapy has revolutionized cancer treatment, but recent studies have revealed the complexity and heterogeneity of CD8 +/- T cell populations in the tumor microenvironment. These studies have also found that CD8 +/- T cell states within and outside the tumor microenvironment have different capacities to respond to immunotherapy.
CANCER IMMUNOLOGY RESEARCH
(2022)
Article
Oncology
Natalija Van Braeckel-Budimir, Joseph Samuel Dolina, Jie Wei, Xiao Wang, Shih-Hsun Chen, Pamela Santiago, Guanghuan Tu, Luca Micci, Amir A. Al-Khami, Sophia Pfister, Sripad Ram, Purnima Sundar, Graham Thomas, Hua Long, Wenjing Yang, Shobha Potluri, Shahram Salek-Ardakani
Summary: Our study identified distinct CD8(+) T cell subtypes with functional and migratory signatures that predict tumor rejection upon treatment, with OX40/4-1BB agonism expanding a stem-like T cell subpopulation. PD-(L)1 blockade synergized with OX40/4-1BB costimulation by enhancing the presence of stem-like TILs via a CXCR3-dependent mechanism, providing new insights into combinatorial immunotherapy.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2021)
Article
Multidisciplinary Sciences
Joseph S. Dolina, Joey Lee, Eugene L. Moore, Jennifer L. Hope, Donald T. Gracias, Takaji Matsutani, Ashu Chawla, Jason A. Greenbaum, Joel Linden, Stephen P. Schoenberger
Summary: During acute infection, CD4(+) regulatory T cells play a crucial role in regulating the immune response by suppressing cytotoxic CD8(+) T lymphocytes through different mechanisms. Early T cells inhibit primary CTL expansion through adenosine production, while late-phase T-regs suppress T cell proliferation through the transfer of cAMP. This study reveals the distinct roles of different T-reg lineages in fine-tuning CTL priming and contraction phases during acute infection.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)